Top of Page
Skip main navigation

Bacopa Study: Nutraceutical for GWI Associated Cognitive Dysfunction & Biological Response

In a Phase I, open label study, we aim to assess safety, feasibility, preliminary evidence of efficacy and biological response of a Nutraceutical as an evidenced Nootropic agent (enhances cognitive function), with multi-mechanistic action.

 For more information, please contact us at 954-262-2870 or email

Visit for study record details.


Return to GWICTIC Studies

Return to top of page